MEREDITH STATON: Open Payments
NPI 1841328101 · LAVONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,131 in 108 payments from 37 companies in 2025. Trend: 2023 $3,076 · 2024 $3,294 · 2025 $3,131
Food & beverage: $2,216Long term medical supply or device loan: $500Education: $416
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $705 |
| ABBVIE INC. | 9 | $205 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| SEAGEN INC. | 2 | $178 |
| Incyte Corporation | 4 | $173 |
| Stemline Therapeutics Inc. | 6 | $153 |
| Lilly USA, LLC | 2 | $125 |
| PFIZER INC. | 7 | $123 |
| Gilead Sciences, Inc. | 4 | $104 |
| PharmaEssentia USA Corporation | 4 | $100 |
Products named: KISQALI, Orserdu, Enhertu, JAYPIRCA, Trodelvy, BESREMI, Nubeqa, Fabhalta.
Industry payments across GA — which companies pay providers there.
